MECHANISM AND PREVENTION OF CHRONIC COLONIC INFLAMMATION WITH TRINITROBENZENE SULFONIC-ACID IN RATS

被引:24
作者
HOSHINO, H
SUGIYAMA, S
OHARA, A
GOTO, H
TSUKAMOTO, Y
OZAWA, T
机构
[1] NAGOYA UNIV, FAC MED, DEPT BIOMED CHEM, SHOWA KU, NAGOYA, AICHI 466, JAPAN
[2] NAGOYA UNIV, FAC MED, DEPT INTERNAL MED, NAGOYA, AICHI 466, JAPAN
来源
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 1992年 / 19卷 / 10期
关键词
CYCLOSPORINE-A; HPLC; INFLAMMATORY BOWEL DISEASE; PROSTAGLANDINS; THROMBOXANE; TRINITROBENZENE SULFONIC ACID;
D O I
10.1111/j.1440-1681.1992.tb00409.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The role of prostanoids in experimental colitis with trinitrobenzene sulfonic acid (TNBS) in rats was investigated. The effects of cyclosporine A (CsA) on the development of experimental colitis were also examined. 2. Five kinds of prostanoids were detected in rat colonic tissue by high performance liquid chromatography. These were 6-keto-prostaglandin (PG) F1alpha, PGF2alpha, PGE2, PGD2 and thromboxane B2. 3. In TNBS-induced experimental colitis, all prostanoid concentrations except PGD2 increased, although the time courses differed from each other. 4. Medication with indomethacin markedly reduced prostanoid concentrations in TNBS-induced colitis. However, indomethacin did not show any effect on damage scores. 5. Cyclosporine A reduced damage scores 14 days after TNBS treatment, and the protective effects were observed, whereas CsA did not affect colonic tissue prostanoid concentrations. 6. Prostanoids might be produced secondarily in the genesis of TNBS-induced colitis, although they may attenuate the inflammatory response. It was also suggested that CsA was likely to have therapeutic effects on experimental colitis by inhibiting the immune reaction with TNBS, which induced the chronic inflammation.
引用
收藏
页码:717 / 722
页数:6
相关论文
共 23 条
  • [1] EFFECTIVE INTRAVENOUS CYCLOSPORINE THERAPY IN A PATIENT WITH SEVERE CROHNS-DISEASE ON PARENTERAL-NUTRITION
    ALLAM, BF
    TILLMAN, JE
    THOMSON, TJ
    CROSSLING, FT
    GILBERT, LM
    [J]. GUT, 1987, 28 (09) : 1166 - 1169
  • [2] TREATMENT WITH 16,16'-DIMETHYL PROSTAGLANDIN-E2 BEFORE AND AFTER INDUCTION OF COLITIS WITH TRINITROBENZENESULFONIC ACID IN RATS DECREASES INFLAMMATION
    ALLGAYER, H
    DESCHRYVER, K
    STENSON, WF
    [J]. GASTROENTEROLOGY, 1989, 96 (05) : 1290 - 1300
  • [3] THE EFFECT OF ANTI-INFLAMMATORY DRUGS ON EICOSANOID FORMATION IN A CHRONIC MODEL OF INFLAMMATORY BOWEL-DISEASE IN THE RAT
    BOUGHTONSMITH, NK
    WALLACE, JL
    MORRIS, GP
    WHITTLE, BJR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (01) : 65 - 72
  • [4] A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED TRIAL OF CYCLOSPORINE THERAPY IN ACTIVE CHRONIC CROHNS-DISEASE
    BRYNSKOV, J
    FREUND, L
    RASMUSSEN, SN
    LAURITSEN, K
    DEMUCKADELL, OS
    WILLIAMS, N
    MACDONALD, AS
    TANTON, R
    MOLINA, F
    CAMPANINI, MC
    BIANCHI, P
    RANZI, T
    DIPALO, FQ
    MALCHOWMOLLER, A
    THOMSEN, OO
    TAGEJENSEN, U
    BINDER, V
    RIIS, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (13) : 845 - 850
  • [5] EFFECTS OF PROSTAGLANDIN-D2 AND OMEPRAZOLE ON INDOMETHACIN-INDUCED GASTRIC-ULCERS IN RATS
    FUKUI, A
    NAKAZAWA, S
    GOTO, H
    SUGIYAMA, S
    OZAWA, T
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1988, 15 (12) : 919 - 926
  • [6] PROSTANOIDS CYTOPROTECTION FOR MAINTAINING REMISSION IN ULCERATIVE-COLITIS - FAILURE OF 15(R), 15-METHYLPROSTAGLANDIN-E2
    GOLDIN, E
    RACHMILEWITZ, D
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1983, 28 (09) : 807 - 811
  • [7] GOTO H, 1987, BIOCHEM INT, V14, P311
  • [8] COLORECTAL LEUKOTRIENE-B4 SYNTHESIS INVITRO IN INFLAMMATORY BOWEL-DISEASE - INHIBITION BY THE SELECTIVE 5-LIPOXYGENASE INHIBITOR BWA4C
    HAWTHORNE, AB
    BOUGHTONSMITH, NK
    WHITTLE, BJR
    HAWKEY, CJ
    [J]. GUT, 1992, 33 (04) : 513 - 517
  • [9] RELATIONSHIP BETWEEN GASTRIC-MUCOSAL PROSTAGLANDIN LEVELS AND HEALING OF GASTRIC-LESIONS IN RATS
    KUROIWA, M
    SUGIYAMA, S
    OHARA, A
    GOTO, H
    TSUKAMOTO, Y
    NAKAZAWA, S
    OZAWA, T
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1990, 17 (11) : 755 - 762
  • [10] KUSUGAMI K, 1989, GASTROENTEROLOGY, V97, P1